123 related articles for article (PubMed ID: 11398611)
81. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
[TBL] [Abstract][Full Text] [Related]
82. Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy.
Chauveinc L; Buthaud X; Falcou MC; Mosseri V; De la Rochefordière A; Pierga JY; Girodet J; Salmon RJ
Br J Cancer; 2003 Dec; 89(11):2057-61. PubMed ID: 14647138
[TBL] [Abstract][Full Text] [Related]
83. Organ preservation in carcinoma of the anal canal.
Valentini V; Mantello G; Leone MV; Luzi S; Turriziani A
Rays; 1997; 22(3):447-53. PubMed ID: 9446949
[TBL] [Abstract][Full Text] [Related]
84. Interstitial hyperthermia and high dose rate brachytherapy in the treatment of anal cancer: a phase I/II study.
Kapp KS; Kapp DS; Stuecklschweiger G; Berger A; Geyer E
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):189-99. PubMed ID: 8270441
[TBL] [Abstract][Full Text] [Related]
85. Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal.
Huang K; Haas-Kogan D; Weinberg V; Krieg R
World J Gastroenterol; 2007 Feb; 13(6):895-900. PubMed ID: 17352019
[TBL] [Abstract][Full Text] [Related]
86. Review of anal cancer patients at the Ottawa hospital.
Abunassar M; Reinders J; Jonker DJ; Asmis T
Eur J Surg Oncol; 2015 May; 41(5):653-8. PubMed ID: 25776438
[TBL] [Abstract][Full Text] [Related]
87. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.
Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801
[TBL] [Abstract][Full Text] [Related]
88. Treatment of anal carcinoma in the elderly: feasibility and outcome of radical radiotherapy with or without concomitant chemotherapy.
Allal AS; Obradovic M; Laurencet F; Roth AD; Spada A; Marti MC; Kurtz JM
Cancer; 1999 Jan; 85(1):26-31. PubMed ID: 9921970
[TBL] [Abstract][Full Text] [Related]
89. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
90. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning.
Wright JL; Patil SM; Temple LK; Minsky BD; Saltz LB; Goodman KA
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1064-72. PubMed ID: 20350793
[TBL] [Abstract][Full Text] [Related]
91. Synchronous chemotherapy and radiotherapy for carcinoma of the anal canal--an alternative to abdominoperineal resection.
Tiver KW; Langlands AO
Aust N Z J Surg; 1984 Apr; 54(2):101-8. PubMed ID: 6430261
[TBL] [Abstract][Full Text] [Related]
92. Anal carcinoma therapy: can we improve on 5-fluorouracil/mitomycin/radiotherapy?
Jiang Y; Mackley H; Cheng H; Ajani JA
J Natl Compr Canc Netw; 2010 Jan; 8(1):135-44. PubMed ID: 20064295
[TBL] [Abstract][Full Text] [Related]
93. Concurrent chemoradiotherapy for squamous cell carcinoma of the anus using a shrinking field radiotherapy technique without a boost.
Melcher AA; Sebag-Montefiore D
Br J Cancer; 2003 May; 88(9):1352-7. PubMed ID: 12778060
[TBL] [Abstract][Full Text] [Related]
94. External beam radiotherapy plus brachytherapy boost in treatment of anal canal carcinoma.
Stojanović S; Radosević-Jelić I; Dabić-Stanković K; Popov I; Josifovski J
Acta Chir Iugosl; 2007; 54(3):33-8. PubMed ID: 17988027
[TBL] [Abstract][Full Text] [Related]
95. Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08.
Konski A; Garcia M; John M; Krieg R; Pinover W; Myerson R; Willett C
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):114-8. PubMed ID: 18472363
[TBL] [Abstract][Full Text] [Related]
96. Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC).
Fish R; Sanders C; Ryan N; der Veer SV; Renehan AG; Williamson PR
Colorectal Dis; 2018 May; 20(5):371-382. PubMed ID: 29566456
[TBL] [Abstract][Full Text] [Related]
97. Interstitial high-dose rate brachytherapy as boost for anal canal cancer.
Falk AT; Claren A; Benezery K; François E; Gautier M; Gerard JP; Hannoun-Levi JM
Radiat Oncol; 2014 Nov; 9():240. PubMed ID: 25377886
[TBL] [Abstract][Full Text] [Related]
98. HDR brachytherapy for anal cancer.
Niehoff P; Kovács G
J Gastrointest Oncol; 2014 Jun; 5(3):218-22. PubMed ID: 24982770
[TBL] [Abstract][Full Text] [Related]
99. Systematic review: anal and rectal changes after radiotherapy for prostate cancer.
Krol R; Smeenk RJ; van Lin EN; Yeoh EE; Hopman WP
Int J Colorectal Dis; 2014 Mar; 29(3):273-83. PubMed ID: 24150230
[TBL] [Abstract][Full Text] [Related]
100. Intracavitary afterloading boost in anal canal carcinoma. Results, function and quality of life.
Vordermark D; Flentje M; Sailer M; Kölbl O
Strahlenther Onkol; 2001 May; 177(5):252-8. PubMed ID: 11398611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
